Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-κB and JNK/AP-1 activation

International Immunopharmacology

Volumn 9, Issue 9, 2009, Pages 1042-1048

  Shan, Jianhua ^a   Fu, Jin ^a   Zhao, Zhihui ^a   Kong, Xiuqin ^a   Huang, Huang ^b   Luo, Lan ^b   Yin, Zhimin ^a  

^a NANJING NORMAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Chlorogenic acid; Cyclooxygenase 2; MAPKs; Nuclear factor B; RAW264.7 cells

Indexed keywords

CHLOROGENIC ACID; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; CELL LINE; CHLOROGENIC ACID; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE KINASE 4; MICE; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 67649400356     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.04.011     Document Type: Article

References (55)

1. Zang L.Y., Cosma G., Gardner H., Castranova V., and Vallyathan V. Effect of chlorogenic acid on hydroxyl radical. Mol Cell Biochem 247 (2003) 205-210
2. Nardini M., Cirillo E., Natella F., and Scaccini C. Absorption of phenolic acids in humans after coffee consumption. J Agric Food Chem 50 (2002) 5735-5741
3. Zhao Z., Shin H.S., Satsu H., Totsuka M., and Shimizu M. 5-Caffeoylquinic acid and caffeic acid down-regulate the oxidative stress- and TNF-α-induced secretion of interleukin-8 from Caco-2 cells. J Agric Food Chem 56 (2008) 3863-3868
4. Almeida A.A., Farah A., Silva D.A., Nunan E.A., and Gloria M.B. Antibacterial activity of coffee extracts and selected coffee chemical compounds against enterobacteria. J Agric Food Chem 54 (2006) 8738-8743
5. Kono Y., Kashine S., Yoneyama T., Sakamoto Y., Matsui Y., and Shibata H. Iron chelation by chlorogenic acid as a natural antioxidant. Biosci Biotechnol Biochem 62 (1998) 22-27
6. Huang M.T., Smart R.C., Wong C.Q., and Conney A.H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 48 (1988) 5941-5946
7. Bandyopadhyay G., Biswas T., Roy K.C., Mandal S., Mandal C., Pal B.C., et al. Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells. Blood 104 (2004) 2514-2522
8. Feng R., Lu Y., Bowman L.L., Qian Y., Castranova V., and Ding M. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 280 (2005) 27888-27895
9. Krakauer T. The polyphenol chlorogenic acid inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines. Immunopharmacol Immunotoxicol 24 (2002) 113-119
10. do Santos M.D., Almeida M.C., Lopes N.P., and de Souza G.E. Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol Pharm Bull 29 (2006) 2236-2240
11. Jin X.H., Ohgami K., Shiratori K., Suzuki K., Koyama Y., Yoshida K., et al. Effects of blue honeysuckle (Lonicera caerulea L.) extract on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp Eye Res 82 (2006) 860-867
12. Rossi A., Longo R., Russo A., Borrelli F., and Sautebin L. The role of the phenethyl ester of caffeic acid (CAPE) in the inhibition of rat lung cyclooxygenase activity by propolis. Fitoterapia 73 (2002) S30-S37
13. Rossi A., Ligresti A., Longo R., Russo A., Borrelli F., and Sautebin L. The inhibition effect of propolis and caffeic acid phenethyl ester on cyclooxygenase activity in J774 macrophages. Phytomedicine 9 (2002) 530-535
14. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
15. Knaus W.A., Sun X., Nystrom O., and Wagner D.P. Evaluation of definitions for sepsis. Chest 101 (1992) 1656-1662
16. Horn K.D. Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS). Q J Med 91 (1998) 265-277
17. Remick D.G., Strieter R.M., Eskandari M.K., Nguyen D.T., Genord M.A., Raiford C.L., et al. Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations. Am J Pathol 136 (1990) 49-60
18. Hsu H.Y., and Wen M.H. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 277 (2002) 22131-22139
19. Yoshimoto T., Nakanishi K., Hirose S., Hiroishi K., Okamura H., Takemoto Y., et al. High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. J Immunol 148 (1992) 3596-3603
20. Wheeler M.A., Smith S.D., Garcia-Cardena G., Nathan C., Weiss R.M., and Sessa W.C. Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest 99 (1997) 110-116
21. Hempel S.L., Monick M.M., and Hunninghake G.W. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 93 (1994) 391-396
22. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 15 (1997) 323-350
23. Guo J.Y., Huo H.R., Yang Y.X., Li C.H., Liu H.B., Zhao B.S., et al. 2-methoxycinnamaldehyde reduces IL-1beta-induced prostaglandin production in rat cerebral endothelial cells. Biol Pharm Bull 29 (2006) 2214-2221
24. Moncada S. Nitric oxide: discovery and impact on clinical medicine. J R Soc Med 92 (1999) 164-169
25. Reddy S.T., Wadleigh D.J., and Herschman H.R. Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells. J Biol Chem 275 (2000) 3107-3113
26. Herschman H.R. Prostaglandin synthase 2. Biochim Biophys Acta 1299 (1996) 125-140
27. Funk C.D., Funk L.B., Kennedy M.E., Pong A.S., and Fitzgerald G.A. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J 5 (1991) 2304-2312
28. Riese J., Hoff T., Nordhoff A., DeWitt D.L., Resch K., and Kaever V. Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation. J Leukoc Biol 55 (1994) 476-482
29. Hwang D., Jang B.C., Yu G., and Boudreau M. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. Biochem Pharmacol 54 (1997) 87-96
30. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269 (1994) 4705-4708
31. Kim J.B., Han A.R., Park E.Y., Kim J.Y., Cho W., Lee J., et al. Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-kappa B inactivation in RAW264.7 macrophage cells. Biol Pharm Bull 30 (2007) 2345-2351
32. Chen Z., Hagler J., Palombella V.J., Melandri F., Scherer D., Ballard D., et al. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 9 (1995) 1586-1597
33. Chan E.D., and Riches D.W. IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38 (mapk) in a mouse macrophage cell line. Am J Physiol Cell Physiol 280 (2001) C441-C450
34. Mestre J.R., Mackrell P.J., Rivadeneira D.E., Stapleton P.P., Tanabe T., and Daly J.M. Redundancy in the signaling pathways and promoter elements regulating cyclooxygenase-2 gene expression in endotoxin-treated macrophage/monocytic cells. J Biol Chem 276 (2001) 3977-3982
35. Yun K.J., Kim J.Y., Kim J.B., Lee K.W., Jeong S.Y., Park H.J., et al. Inhibition of LPS-induced NO and PGE(2) production by asiatic acid via NF-kappaB inactivation in RAW264.7 macrophages: possible involvement of the IKK and MAPK pathways. Int Immunopharmacol 8 (2008) 431-441
36. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81 (2001) 807-869
37. Xue B., Wu Y., Yin Z., Zhang H., Sun S., Yi T., et al. Regulation of lipopolysaccharide-induced inflammatory response by glutathione S-transferase P1 in RAW264.7 cells. FEBS Lett 579 (2005) 4081-4087
38. Wisdom R. AP-1: one switch for many signals. Exp Cell Res 253 (1999) 180-185
39. Zhang S., Thomas K., Blanco J.C., Salkowski C.A., and Vogel S.N. The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro. J Endotoxin Res 8 (2002) 379-388
40. Tsatsanis C., Androulidaki A., Venihaki M., and Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 38 (2006) 1654-1661
41. Kang Y.J., Wingerd B.A., Arakawa T., and Smith W.L. Cyclooxygenase-2 gene transcriptional in a macrophage model of inflammation. J Immunol 177 (2006) 8111-8122
42. Wu Y.F., Fan Y.M., Xue B., Luo L., Shen J.Y., and Yin Z.M. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25 (2006) 5787-5800
43. Kim S.F., Huri D.A., and Snyder S.H. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310 (2005) 1966-1970
44. Nath J., and Powledge A. Modulation of human neutrophil inflammatory responses by nitric oxide: studies in unprimed and LPS-primed cells. J Leukoc Biol 62 (1997) 805-816
45. Baeuerle P.A., and Henkel T. Function and activation of NF-kappaB in the immune system. Annu Rev Immunol 12 (1994) 141-179
46. Barnes P.J. Nuclear factor-kappaB. Int J Biochem Cell Biol 29 (1997) 867-870
47. Jang B.C., Paik J.H., Kim S.P., Shin D.H., Song D.K., Park J.G., et al. Catalase induced expression of inflammatory mediators via activation of NF-kappaB, PI3K/AKT, p70S6K, and JNKs in BV2 microglia. Cell Signal 17 (2005) 625-633
48. Rainsford K.D. Anti-infl{ligature}ammatory drugs in the 21st century. Sub-cell Biochem 42 (2007) 3-27
49. Tsatsanis C., Androulidaki A., Venihaki M., and Margioris A.N. Signaling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 38 (2006) 1654-1661
50. Wadleigh D.J., Reddy S.T., Kopp E., Ghosh S., and Herschman H.R. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem 275 (2000) 6259-6266
51. Kang Y.J., Wingerd B.A., Arakawa T., and Smith W.L. Cyclooxygenase-2 gene transcription in a macrophage model of inflammation. J Immunol 177 (2006) 8111-8112
52. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad. Sci U S A 90 (1993) 9730-9734
53. Tegeder I., Niederberger E., Israr E., Guhring H., Brune K., Euchenhofer C., et al. Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J 15 (2001) 2-4
54. Tegeder I., Pfeilschifter J., and Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 15 (2001) 2057-2072
55. Ryu M., Kim E.H., Chun M., Kang S., Shim B., Yu Y.B., et al. Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p38 and Erk. J Ethnopharmacol 115 (2007) 184-193